Our team conducts innovative research to test and implement brain-gut behavioral therapies with the goal of improving symptoms and quality of life for those with irritable bowel syndrome, ulcerative colitis, and Crohn’s disease.

Our team is beginning to explore abdominal pain among individuals with inflammatory bowel disease.